Your browser doesn't support javascript.
loading
Which diabetes specific patient reported outcomes should be measured in routine care? A systematic review to inform a core outcome set for adults with Type 1 and 2 diabetes mellitus: The European Health Outcomes Observatory (H2O) programme.
Hamilton, Kathryn; Forde, Rita; Due-Christensen, Mette; Eeg-Olofson, Katarina; Nathanson, David; Rossner, Sophia; Vikstrom-Greve, Sara; Porth, Ann-Kristin; Seidler, Yuki; Kautzky-Willer, Alexandra; Delbecque, Laure; Ozdemir Saltik, Asli Zeynep; Hasler, Yvonne; Flores, Vanesa; Stamm, Tanja; Hopkins, David; Forbes, Angus.
Afiliação
  • Hamilton K; Kings College London, Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care, London, UK. Electronic address: Kathryn.hamilton@kcl.ac.uk.
  • Forde R; Kings College London, Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care, London, UK.
  • Due-Christensen M; Kings College London, Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care, London, UK.
  • Eeg-Olofson K; University of Gothenburg, Institute of Medicine, Department of Molecular and Clinical Medicine, Gothenburg, Sweden.
  • Nathanson D; Karolinska Institutet, Department of Medicine, Huddinge, Sweden; Karolinska University Hospital, Medical Unit Endocrinology, Huddinge, Sweden.
  • Rossner S; Karolinska Institutet, Department of Medicine, Huddinge, Sweden.
  • Vikstrom-Greve S; Karolinska Institutet, Department of Medicine, Huddinge, Sweden; Karolinska University Hospital, Medical Unit Endocrinology, Huddinge, Sweden.
  • Porth AK; Medical University of Vienna, Gender Medicine Unit, Division of Endocrinology and Metabolism, Department of Internal Medicine III, Vienna, Austria.
  • Seidler Y; Medical University of Vienna, Institute of Outcomes Research, Center for Medical Statistics and Informatics, Vienna, Austria.
  • Kautzky-Willer A; Medical University of Vienna, Gender Medicine Unit, Division of Endocrinology and Metabolism, Department of Internal Medicine III, Vienna, Austria.
  • Delbecque L; Eli Lilly and Company, Indianapolis, USA.
  • Ozdemir Saltik AZ; Medtronic International Trading Sàrl, Tolochenaz, Switzerland.
  • Hasler Y; Medtronic International Trading Sàrl, Tolochenaz, Switzerland.
  • Flores V; Vall d'Hebron University Hospital, Vall d'Hebron Institute of Research, Barcelona, Spain.
  • Stamm T; Medical University of Vienna, Institute of Outcomes Research, Center for Medical Statistics and Informatics, Vienna, Austria; Ludwig Boltzmann Institute for Arthritis and Rehabilitation, Vienna, Austria.
  • Hopkins D; King's Health Partners Institute for Diabetes, Endocrinology and Obesity, London, UK.
  • Forbes A; Kings College London, Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care, London, UK.
Patient Educ Couns ; 116: 107933, 2023 11.
Article em En | MEDLINE | ID: mdl-37672919
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 / Diabetes Mellitus Tipo 2 Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 1 / Diabetes Mellitus Tipo 2 Idioma: En Ano de publicação: 2023 Tipo de documento: Article